GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析

◆英語タイトル:GeNeuro SA (GNRO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14948
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GeNeuro SA (GeNeuro) is a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develops therapeutic products for neurological disorders such as multiple sclerosis, schizophrenia and other diseases of the nervous system. The company offers therapeutic monoclonal antibodies to neutralize the immunopathogenic multiple sclerosis associated RetroViral element envelope proteins detected in MS brain plaques. It develops therapeutics for nervous system pathologies involving human endogenous retroviruses. GeNeuro is headquartered in Geneva, Switzerland.

GeNeuro SA Key Recent Developments

Jan 29,2019: GeNeuro: cash position at 31 December 2018 and business review
Oct 03,2018: GeNeuro Announces Positive 6-Month Phase IIa Data for GNbAC1 in Adults with Type 1 Diabetes
Jul 26,2018: GeNeuro: financial information and business update for the second quarter 2018
May 09,2018: GeNeuro Announces Financial Information and Business Update for the First Quarter 2018

This comprehensive SWOT profile of GeNeuro SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of GeNeuro SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

GeNeuro SA – Key Information
GeNeuro SA – Overview
GeNeuro SA – Key Employees
GeNeuro SA – Key Employee Biographies
GeNeuro SA – Key Operational Heads
GeNeuro SA – Major Products and Services
GeNeuro SA – History
GeNeuro SA – Company Statement
GeNeuro SA – Locations And Subsidiaries
GeNeuro SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

GeNeuro SA – Business Description
GeNeuro SA – Corporate Strategy
GeNeuro SA – SWOT Analysis
SWOT Analysis – Overview
GeNeuro SA – Strengths
GeNeuro SA – Weaknesses
GeNeuro SA – Opportunities
GeNeuro SA – Threats
GeNeuro SA – Key Competitors

Section 3 – Company Financial Performance Charts

GeNeuro SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

GeNeuro SA, Key Information
GeNeuro SA, Key Ratios
GeNeuro SA, Share Data
GeNeuro SA, Major Products and Services
GeNeuro SA, History
GeNeuro SA, Key Employees
GeNeuro SA, Key Employee Biographies
GeNeuro SA, Key Operational Heads
GeNeuro SA, Other Locations
GeNeuro SA, Subsidiaries
GeNeuro SA, Key Manufacturing facilities
GeNeuro SA, Key Competitors
GeNeuro SA, SWOT Analysis
GeNeuro SA, Ratios based on current share price
GeNeuro SA, Annual Ratios
GeNeuro SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

GeNeuro SA, Performance Chart
GeNeuro SA, Ratio Charts

★海外企業調査レポート[GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AGL Energy Ltd (AGL):企業の財務・戦略的SWOT分析
    AGL Energy Ltd (AGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • QBE Insurance (Vietnam) Company Ltd:企業の戦略的SWOT分析
    QBE Insurance (Vietnam) Company Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Tersus Energy Ltd:企業の戦略的SWOT分析
    Tersus Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • ReWalk Robotics Ltd (RWLK):企業の財務・戦略的SWOT分析
    Summary ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company offers walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabilita …
  • SK Bioland Co Ltd:企業の戦略・SWOT・財務分析
    SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report Summary SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Recepta Biopharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Recepta Biopharma SA (Recepta) is a biotechnology company that offers research and development of drugs used in the treatment of cancer. The company offers antibodies and peptide products. It offers antibodies such as monoclonal antibody hu3s193 - anti-ley, monoclonal antibody 58-1066 - anti …
  • ProQR Therapeutics NV (PRQR):企業の財務・戦略的SWOT分析
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, anti …
  • Bartlett Cocke General Contractors:企業の戦略・SWOT・財務情報
    Bartlett Cocke General Contractors - Strategy, SWOT and Corporate Finance Report Summary Bartlett Cocke General Contractors - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Core-Mark Holding Company, Inc.:企業の戦略・SWOT・財務情報
    Core-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Core-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Polskie Sieci Elektroenergetyczne SA:企業の戦略的SWOT分析
    Polskie Sieci Elektroenergetyczne SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Oando Plc (OANDO):企業の財務・戦略的SWOT分析
    Oando Plc (OANDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Carrizo Oil & Gas Inc (CRZO):石油・ガス:M&Aディール及び事業提携情報
    Summary Carrizo Oil & Gas Inc (Carrizo) is an independent oil and gas company, which carries out exploration, development and production of oil and natural gas from several resources plays. It has presence in the Eagle Ford Shale in South Texas and the Delaware Basin in West Texas. The company princ …
  • Andorra Banc Agricol Reig SA:企業の戦略・SWOT・財務情報
    Andorra Banc Agricol Reig SA - Strategy, SWOT and Corporate Finance Report Summary Andorra Banc Agricol Reig SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • US WorldMeds LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary US WorldMeds LLC (US WorldMeds) is a specialty pharmaceutical company that develops, licenses and markets healthcare products to improve lives of patients with challenging conditions and unmet medical needs. The company’s products comprise apokyn, myobloc and revonto. Its apokyn is used for …
  • Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析
    Jiangsu Hengrui Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Scapa Group plc (SCPA):企業の財務・戦略的SWOT分析
    Scapa Group plc (SCPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • New Standard Energy Ltd (NSE):企業の財務・戦略的SWOT分析
    Summary New Standard Energy Ltd (NSE), formerly Hawk Resources Ltd, is an oil and gas exploration and production company. The company carries out acquisition, exploration, and develops oil and gas; and hydrocarbon properties. It holds interest in production and development project in the Eagle Ford …
  • Mahagenco:企業の戦略的SWOT分析
    Mahagenco - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆